Fadlo R Khuri

发表

Research biopsies in phase I studies: views and perspectives of participants and investigators.

Zhengjia Chen, Colleen Lewis, Rebecca D Pentz, 2012, IRB.

caGrid-Enabled caBIGTM Silver Level Compatible Head and Neck Cancer Tissue Database System

Mourad Tighiouart, André Rogatko, Zhengjia Chen, 2010, The open medical informatics journal.

New Paradigm in Dose-Finding Trials: Patient-Specific Dosing and Beyond Phase I

Mourad Tighiouart, André Rogatko, Fadlo R Khuri, 2005, Clinical Cancer Research.

Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.

Ximei Qian, Shuming Nie, Zhuo Georgia Chen, 2011, Cancer research.

Chemoprevention strategies for patients with lung cancer in the context of screening.

Fadlo R Khuri, F. Khuri, N. Saba, 2005, Clinical lung cancer.

Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.

Haian Fu, Fadlo R Khuri, F. Khuri, 2006, Seminars in cancer biology.

MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development

Lee A D Cooper, Margaret A. Johns, Yuhong Du, 2017, PloS one.

The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT.

Jing Chen, Fadlo R Khuri, F. Khuri, 2005, Blood.

6-phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumor growth by inhibiting LKB1-AMPK signaling

Jing Chen, Taro Hitosugi, Jianxin Xie, 2014, Nature Cell Biology.

Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

Jing Chen, Taro Hitosugi, Jianxin Xie, 2009, Science Signaling.

Translation of innovative designs into phase I trials.

Mourad Tighiouart, André Rogatko, William Jonas, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.

Fadlo R Khuri, F. Khuri, J. Roman, 2006, Cancer research.

Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect*

Jing Chen, Jianxin Xie, Changliang Shan, 2014, The Journal of Biological Chemistry.

p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.

Zhuo Georgia Chen, Taro Hitosugi, Wei Zhou, 2010, The Journal of clinical investigation.

Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.

Li Mao, Fadlo R Khuri, Diane D. Liu, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Statistical learning methods as a preprocessing step for survival analysis: evaluation of concept using lung cancer data

John J Heine, Taofeek K Owonikoko, Fadlo R Khuri, 2011, Biomedical engineering online.

Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants

Jian Gu, J Jack Lee, Yuanqing Ye, 2009, Cancer Prevention Research.

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Li Mao, Fadlo R Khuri, Diane D. Liu, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis.

Michael Goodman, Kristin Higgins, Taofeek K Owonikoko, 2015, Oral oncology.

The known unknown

Fadlo R Khuri, 2017, Cancer.

Interactive Software “Isotonic Design using Normalized Equivalent Toxicity Score (ID-NETS©TM)” for Cancer Phase I Clinical Trials

Jeanne Kowalski, Taofeek K Owonikoko, Fadlo R Khuri, 2013, The open medical informatics journal.

Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials.

Jeanne Kowalski, Ruiyan Luo, Taofeek K Owonikoko, 2014, Contemporary clinical trials.

Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.

Jing Chen, Taro Hitosugi, Chuan He, 2014, Molecular cell.

Mode of action of docetaxel - a basis for combination with novel anticancer agents.

Roy S Herbst, Fadlo R Khuri, F. Khuri, 2003, Cancer treatment reviews.

A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors.

Yuhong Du, Haian Fu, Fadlo R Khuri, 2013, Assay and drug development technologies.

hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.

Li Mao, Fadlo R Khuri, Diane D. Liu, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Li Mao, B Nebiyou Bekele, Fadlo R Khuri, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Altered glutamine metabolism and therapeutic opportunities for lung cancer.

Taofeek K Owonikoko, Fadlo R Khuri, Xingming Deng, 2014, Clinical lung cancer.

Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.

Lin Ji, Hojin Moon, Fadlo R Khuri, 2004, Journal of the National Cancer Institute.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Michael M Lieber, J Michael Gaziano, Ian M Thompson, 2005, Journal of the National Cancer Institute.

Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.

Taro Hitosugi, Gary LeRoy, Chuan He, 2012, Cancer cell.